CLL and MCL have a non-genetic mechanism of BCR signaling where stereotyped BCRs and biased usage of unmutated immunoglobulin heavy-chain variable-region gene (IGHV) support the presence of cognate self-antigen leading to chronic BCR activation (8, 9). This evidence concerns the gene SLC3A2 and B-cell chronic lymphocytic leukemia.